Til hovedinnhold
Norli Bokhandel

Drug Target Selection and Validation

2022, Innbundet, Engelsk

1 569,-

Bestillingsvare – sendes normalt innen 10-14 virkedager
  • Ikke tilgjengelig for hent i butikk
The first book in the newly created book series, Computer-Aided Drug Discovery and Design, focuses on the computational aspects of early drug discovery, drug target identification, and validation. It revises current classical paradigms in target and phenotypic-based drug design with still ingrained approximations and concepts and discusses the research in the new network approach concept that include kinetic selectivity and metabolic analysis. Many often-overlooked approximations and concepts in drug discovery are fully covered. Drug Target Selection and Validation includes both introductory sections and research-based sections to be of use to both students and research scientists in drug discovery, design, kinetics and metabolic analysis.  Pharmaceutical scientists, pharmaceutics, drug developers, pharmacologists, biomedical researchers in computer science, medicinal chemists, and precision medicine developers benefit from the information provided.  The book concludes with a chapter on chemical and structural databases.

Produktegenskaper

  • Bidragsyter

    Carolina L. Bellera (Redaktør) ; Marcus T. Scotti (Redaktør)
  • Forlag/utgiver

    Springer Nature Switzerland AG
  • Format

    Innbundet
  • Språk

    Engelsk
  • Utgivelsesår

    2022
  • Antall sider

    257
  • Serienavn

    Computer-Aided Drug Discovery and Design
  • Utgivelsesdato

    18.05.2022
  • Varenummer

    9783030958947

Kundeanmeldelser

Frakt og levering